Skip to main content

Suprajit Engineering Retains FY27 EBITDA Margin Guidance At 12%-13.5%

Suprajit Engineering reaffirmed its full-year FY27 consolidated EBITDA margin outlook of 12% to 13.5% while projecting margin improvement in H2 FY27. Solid operational performance in Q2 FY27 saw consolidated revenue expansion of over 20% and an EBITDA margin of 12.2%.

Author Image
Sahi Markets
Published: 17 Nov 2026, 05:45 PM IST (2 hours ago)
Last Updated: 17 Nov 2026, 05:45 PM IST (2 hours ago)
2 min read
Reviewed by Arpit Seth

Market snapshot: Suprajit Engineering has reiterated its full-year FY27 consolidated EBITDA margin guidance in the 12% to 13.5% band. The management anticipates a slight sequential operational margin expansion in the second half of the fiscal year following a recovery in key operating units.

Data Snapshot

  • Consolidated EBITDA margin guidance for FY27 held steady at 12% to 13.5%.
  • Q2 FY27 consolidated revenue grew by more than 20% with EBITDA margins reaching 12.2%.

What's Changed

  • Margin trajectory normalized in Q2 FY27 after pricing pressures affected initial quarter performance.
  • H2 FY27 operational outlook reflects expected sequential margin expansion, reinforcing the full-year target band.

Key Takeaways

  • Management maintains a disciplined margin corridor of 12% to 13.5% for consolidated FY27 operations.
  • Operational recovery in key divisions supported Q2 FY27 EBITDA growth of 27% year-on-year.
  • Second-half auto OEM demand seasonality is expected to underpin volume growth and operational leverage.

SAHI Perspective

Suprajit Engineering's decision to maintain its 12%-13.5% EBITDA margin corridor underlines operational stability across its core automotive cable and mechatronics divisions. The expected margin gains in H2 FY27 indicate that transitory cost pressures encountered earlier in the fiscal year are abating, driven by operational efficiencies and pricing adjustments.

Market Implications

Confirmation of margin guidance reduces earnings uncertainty for auto ancillary investors. Steady operating profitability amidst input cost volatility positions the company favorably relative to broader sector peers facing margin compression.

Trading Signals

Market Bias: Bullish

Reiterated margin guidance of 12%-13.5% alongside Q2 revenue growth above 20% and EBITDA margins of 12.2% signals strong earnings visibility for H2 FY27.

Overweight: Auto Components & Equipments, Automotive Ancillaries

Trigger Factors:

  • Sustained OEM production recovery in H2 FY27
  • Margin delivery within the 12%-13.5% guided range during Q3 FY27
  • Raw material cost stability across domestic and international operations

Time Horizon: Medium-term (3-12 months)

Industry Context

The Indian auto components industry typically experiences stronger volume demand in the second half of the financial year. As major OEMs ramp up production, leading component suppliers benefit from operating leverage and scale efficiencies.

Key Risks to Watch

  • Export market slowdown affecting overseas divisions
  • Potential raw material input price spikes impacting unit economics
  • Currency volatility across international operating subsidiaries

Recent Developments

Suprajit Engineering reported Q2 FY27 consolidated revenue growth of over 20% and EBITDA growth of 27% with EBITDA margins reaching 12.2%, benefiting from operational recovery across divisions.

Closing Insight

Maintaining full-year guidance of 12%-13.5% highlights execution clarity. Investors should monitor H2 FY27 volume execution to confirm the projected operational margin uplift.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics

Add Sahi as a Preferred Source on Google

Click the link, confirm the box next to sahi.com is checked — ignore any other results.